Adriano D Andricopulo

University of São Paulo, San Paulo, São Paulo, Brazil

Are you Adriano D Andricopulo?

Claim your profile

Publications (140)286.55 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: The natural fatty acids (5Z)-5-pentacosenoic and (9Z)-9-pentacosenoic acids were synthesized for the first time in eight steps starting from either 4-bromo-1-butanol or 8-bromo-1-butanol and in 20-58 % overall yields, while the novel fatty acids 5-pentacosynoic and 9-pentacosynoic acids were also synthesized in six steps and in 34-43 % overall yields. The ∆(5) acids displayed the best IC50's (24-38 µM) against the HIV-1 reverse transcriptase (RT) enzyme, comparable to nervonic acid (IC50 = 12 µM). The ∆(9) acids were not as effective towards HIV-RT with the (9Z)-9-pentacosenoic acid displaying an IC50 = 54 µM and the 9-pentacosynoic acid not inhibiting the enzyme at all. Fatty acid chain length and position of the unsaturation was important for the observed inhibition. None of the synthesized fatty acids were toxic (IC50 > 500 µM) towards peripheral blood mononuclear cells. Molecular modeling studies indicated the structural determinants underlying the biological activity of the most potent compounds. These results provide new insights into the structural requirements that must be present in fatty acids so as to enhance their inhibitory potential towards HIV-RT.
    Lipids 09/2015; 50(10). DOI:10.1007/s11745-015-4064-2 · 1.85 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: 1H high-resolution magic angle spinning nuclear magnetic resonance (1H HR–MAS NMR) spectroscopy was used to analyze the metabolic profile of an intact non-tumor breast cell line (MCF-10A) and intact breast tumor cell lines (MCF-7 and MDA-MB-231). In the spectra of MCF-10A cells, six metabolites were assigned, with glucose and ethanol in higher concentrations. Fifteen metabolites were assigned in MCF-7 and MDA-MB-231 1H HR–MAS NMR spectra. They did not show glucose and ethanol, and the major component in both tumor cells was phosphocholine (higher in MDA-MB-231 than in MCF-7), which can be considered as a tumor biomarker of breast cancer malignant transformation. These tumor cells also show acetone signal that was higher in MDA-MB-231 cells than in MCF-7 cells. The high acetone level may be an indication of high demand for energy in MDA-MB-231 to maintain cell proliferation. The higher acetone and phosphocholine levels in MDA-MB-231 cells indicate the higher malignance of the cell line. Therefore, HR–MAS is a rapid reproducible method to study the metabolic profile of intact breast cells, with minimal sample preparation and contamination, which are critical in the analyses of slow-growth cells.
    Analytical Biochemistry 08/2015; 488. DOI:10.1016/j.ab.2015.07.015 · 2.22 Impact Factor
  • Source
    Leonardo G Ferreira · Ricardo N dos Santos · Glaucius Oliva · Adriano D Andricopulo ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Pharmaceutical research has successfully incorporated a wealth of molecular modeling methods, within a variety of drug discovery programs, to study complex biological and chemical systems. The integration of computational and experimental strategies has been of great value in the identification and development of novel promising compounds. Broadly used in modern drug design, molecular docking methods explore the ligand conformations adopted within the binding sites of macromolecular targets. This approach also estimates the ligand-receptor binding free energy by evaluating critical phenomena involved in the intermolecular recognition process. Today, as a variety of docking algorithms are available, an understanding of the advantages and limitations of each method is of fundamental importance in the development of effective strategies and the generation of relevant results. The purpose of this review is to examine current molecular docking strategies used in drug discovery and medicinal chemistry, exploring the advances in the field and the role played by the integration of structure- and ligand-based methods.
    Molecules 07/2015; 20(7):13384-13421. DOI:10.3390/molecules200713384 · 2.42 Impact Factor
  • Source
    Ricardo N. dos Santos · Faruck Morcos · Biman Jana · Adriano D. Andricopulo · José N. Onuchic ·
    [Show abstract] [Hide abstract]
    ABSTRACT: We develop a procedure to characterize the association of protein structures into homodimers using coevolutionary couplings extracted from Direct Coupling Analysis (DCA) in combination with Structure Based Models (SBM). Identification of dimerization contacts using DCA is more challenging than intradomain contacts since direct couplings are mixed with monomeric contacts. Therefore a systematic way to extract dimerization signals has been elusive. We provide evidence that the prediction of homodimeric complexes is possible with high accuracy for all the cases we studied which have rich sequence information. For the most accurate conformations of the structurally diverse dimeric complexes studied the mean and interfacial RMSDs are 1.95Å and 1.44Å, respectively. This methodology is also able to identify distinct dimerization conformations as for the case of the family of response regulators, which dimerize upon activation. The identification of dimeric complexes can provide interesting molecular insights in the construction of large oligomeric complexes and be useful in the study of aggregation related diseases like Alzheimer's or Parkinson's.
    Scientific Reports 07/2015; 5(1):13652. DOI:10.1038/srep13652 · 5.58 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diapocynin has been regarded as the active principle of apocynin, which is the most used inhibitor of NADPH oxidase. Here we performed a comprehensive study of the interaction of diapocynin with human serum albumin (HSA). We found that diapocynin binds with higher efficacy to site I of HSA and its binding constant (8.5x105 mol-1L) was almost 100-fold higher compared to apocynin. By interacting with this chiral cavity of the protein, diapocynin became a chiral molecule, which was evidenced by its induced circular dichroism spectrum. The axial chirality was theoretically confirmed by searching the most stable conformations adopted by diapocynin using the Density Function Theory (DFT). The four minimum energy conformers, which presented dihedral angles of 58.00° and 302.00° (syn-aS and syn-aR enantiomers pair bearing 2,2'-dihydroxyl groups at the same side) and 132.86° and 227.14° (anti-aS and anti-aR enantiomers pair bearing 2,2'-dihydroxyl groups at opposite sides) were used as initial conformations for the docking simulations. The highest scored docking pose was obtained for site 1 and the dihedral angle resulted in 106.44°, i.e., an anti-aS chiral conformer. In conclusion, diapocynin is a strong ligand of HSA. An unprecedented combination of DFT calculation and docking simulation was used to explain the acquired chirality of diapocynin when bound to HSA.
    RSC Advances 07/2015; 5(76). DOI:10.1039/C5RA10960D · 3.84 Impact Factor
  • Leonardo G Ferreira · Adriano D Andricopulo ·
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV-1 protease is a key enzyme for viral maturation because it cleaves precursor polypeptides into mature structural and functional proteins. The introduction of protease inhibitors into therapy in the mid-1990s has dramatically changed the AIDS panorama worldwide. However, resistance to currently available protease inhibitors remains a serious challenge that must be overcome. Herein, we report a fragment-based QSAR study of a series of highly potent HIV-1 protease inhibitors, as well as the structural basis of their binding affinity. Hologram QSAR (HQSAR) analyses were performed, resulting in robust statistical models that consistently correlated the bioactivity profile with the two-dimensional molecular descriptors. The robustness of the best model was assessed based on the correlation coefficients (q(2) = 0.70 and r(2) = 0.90), as well as the prediction of the activity of an external test set (r(2)pred = 0.75). Structure-based molecular modeling studies were performed to investigate the binding mode of the best inhibitor in the active site of the enzyme. The HQSAR model and the structural findings provide valuable insights for the rational design of structurally related HIV-1 protease inhibitors.
    Combinatorial chemistry & high throughput screening 05/2015; 18(5). DOI:10.2174/1386207318666150508095331 · 1.22 Impact Factor
  • Source
    Leonardo G Ferreira · Glaucius Oliva · Adriano D Andricopulo ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Schistosomiasis, a neglected tropical disease caused by worms from the class Trematoda (genus Schistosoma), is a serious chronic condition that has been reported in approximately 80 countries. Nearly 250 million people are affected worldwide, mostly in the sub-Saharan Africa. Praziquantel, the mainstay of treatment, has been used for 30 years, and cases of resistance have been reported. The purpose of this perspective is to discuss current target-based molecular modeling strategies in schistosomiasis drug discovery. Advances in the field and the role played by the integration between computational modeling and experimental validation are also discussed. Finally, recent cases of the contribution of modern approaches in computational medicinal chemistry to the field are explored.
    Future medicinal chemistry 04/2015; 7(6):753-64. DOI:10.4155/fmc.15.21 · 3.74 Impact Factor

  • 7th Brazilian Symposium on Medicinal Chemistry, Campos do Jordão - SP; 11/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The malaria parasite Plasmodium goes through two life stages in the human host, a non-symptomatic liver stage (LS) followed by a blood stage with all clinical manifestation of the disease. In this study, we investigated a series of 2-alkynoic fatty acids (2-AFAs) with chain lengths between 14 and 18 carbon atoms for dual in vitro activity against both life stages. 2-Octadecynoic acid (2-ODA) was identified as the best inhibitor of Plasmodium berghei parasites with ten times higher potency (IC50=0.34μg/ml) than the control drug. In target determination studies, the same compound inhibited three Plasmodium falciparum FAS-II (PfFAS-II) elongation enzymes PfFabI, PfFabZ, and PfFabG with the lowest IC50 values (0.28-0.80μg/ml, respectively). Molecular modeling studies provided insights into the molecular aspects underlying the inhibitory activity of this series of 2-AFAs and a likely explanation for the considerably different inhibition potentials. Blood stages of P. falciparum followed a similar trend where 2-ODA emerged as the most active compound, with 20 times less potency. The general toxicity and hepatotoxicity of 2-AFAs were evaluated by in vitro and in vivo methods in mammalian cell lines and zebrafish models, respectively. This study identifies 2-ODA as the most promising antiparasitic 2-AFA, particularly towards P. berghei parasites.
    Bioorganic & Medicinal Chemistry Letters 07/2014; 24(17). DOI:10.1016/j.bmcl.2014.07.050 · 2.42 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hybrid bioisoster derivatives from N-acylhydrazones and furoxan groups were designed with the objective of obtaining at least a dual mechanism of action: cruzain inhibition and nitric oxide (NO) releasing activity. Fifteen designed compounds were synthesized varying the substitution in N-acylhydrazone and in furoxan group as well. They had its anti-Trypanosoma cruzi activity in amastigotes forms, NO releasing potential and inhibitory cruzain activity evaluated. The two most active compounds (6, 14) both in the parasite amastigotes and in the enzyme contain the nitro group in para position of the aromatic ring. The permeability screening in Caco-2 cell and cytotoxicity assay in human cells were performed for those most active compounds and both showed to be less cytotoxic than the reference drug, benznidazole. Compound 6 was the most promising, since besides activity it showed good permeability and selectivity index, higher than the reference drug. Thereby the compound 6 was considered as a possible candidate for additional studies.
    European Journal of Medicinal Chemistry 06/2014; 82C:418-425. DOI:10.1016/j.ejmech.2014.05.077 · 3.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The development of cruzain inhibitors has been driven by the urgent need to develop novel and more effective drugs for the treatment of Chagasꞌ disease. Herein, we report the lead optimization of a class of noncovalent cruzain inhibitors, starting from an inhibitor previously co-crystallized with the enzyme (Ki = 0.8 µM). With the goal of achieving a better understanding of the structure-activity relationships (SARs), we have synthesized and evaluated a series of over 40 analogues, leading to the development of a very promising competitive inhibitor (8r, IC50 = 200 nM, Ki = 82 nM). Investigation of the in vitro trypanocidal activity and preliminary cytotoxicity revealed the potential of the most potent cruzain inhibitors in guiding further medicinal chemistry efforts to develop drug candidates for Chagasꞌ disease.
    Journal of Medicinal Chemistry 02/2014; 57(6). DOI:10.1021/jm401709b · 5.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chemometric pattern recognition techniques were employed in order to obtain Structure-Activity Relationship (SAR) models relating the structures of a series of adenosine compounds to the affinity for glyceraldehyde 3-phosphate dehydrogenase of Leishmania mexicana (LmGAPDH). A training set of 49 compounds was used to build the models and the best ones were obtained with one geometrical and four electronic descriptors. Classification models were externally validated by predictions for a test set of 14 compounds not used in the model building process. Results of good quality were obtained, as verified by the correct classifications achieved. Moreover, the results are in good agreement with previous SAR studies on these molecules, to such an extent that we can suggest that these findings may help in further investigations on ligands of LmGAPDH capable of improving treatment of leishmaniasis.
    International Journal of Molecular Sciences 02/2014; 15(2):3186-203. DOI:10.3390/ijms15023186 · 2.86 Impact Factor
  • Adriano Andricopulo · Leonardo Ferreira ·

    01/2014; 2(1):20-31. DOI:10.12970/2308-8044.2014.02.01.4

  • 15th Brazilian Meeting on Organic Synthesis; 12/2013
  • D. C. Fernandes · R. N. S. Santos · M. T. R Júnior · A. D. Andricopulo · F. Coelho ·

    15th Brazilian Meeting on Organic Synthesis; 12/2013
  • Fernando V Maluf · Adriano D Andricopulo · Glaucius Oliva · Rafael Vc Guido ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Chagas disease is a major cause of morbidity and death for millions of people in Latin America. The drugs currently available exhibit poor efficacy and severe side effects. Therefore, there is an urgent need for new, safe and effective drugs against Chagas disease. The vital dependence on glycolysis as energy source makes the glycolytic enzymes of Trypanosoma cruzi, the causative agent of Chagas disease, attractive targets for drug design. In this work, glyceraldehyde-3-phosphate dehydrogenase from T. cruzi (TcGAPDH) was employed as molecular target for the discovery of new inhibitors as hits. Results: Integrated protein-based pharmacophore and structure-based virtual screening approaches resulted in the identification of three hits from three chemical classes with moderate inhibitory activity against TcGAPDH. The inhibitors showed IC50 values in the high micromolar range. Conclusion: The new chemotypes are attractive molecules for future medicinal chemistry efforts aimed at developing new lead compounds for Chagas disease.
    Future medicinal chemistry 11/2013; 5(17):2019-35. DOI:10.4155/fmc.13.166 · 3.74 Impact Factor
  • Leonardo G Ferreira · Adriano D Andricopulo ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Sleeping sickness is a major cause of death in Africa. Since no secure treatment is available, the development of novel therapeutic agents is urgent. In this context, the enzyme trypanothione reductase (TR) is a prominent molecular target that has been investigated in drug design for sleeping sickness. Results: In this study, comparative molecular field analysis models were generated for a series of Trypanosoma brucei TR inhibitors. Statistically significant results were obtained and the models were applied to predict the activity of external test sets, with good correlation between predicted and experimental results. We have also investigated the structural requirements for the selective inhibition of the parasite's enzyme over the human glutathione reductase. Conclusion: The quantitative structure-activity relationship models provided valuable information regarding the essential molecular requirements for the inhibitory activity upon the target protein, providing important insights into the design of more potent and selective TR inhibitors.
    Future medicinal chemistry 10/2013; 5(15):1753-62. DOI:10.4155/fmc.13.140 · 3.74 Impact Factor
  • Ricardo N. Santos · Adriano D. Andricopulo ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Medicinal chemistry is a multidisciplinary subject that integrates knowledge from a variety of fields of science, including, but not limited to, chemistry, biology, and physics. The area of drug design involves the cooperative work of scientists with a diverse range of backgrounds and technical skills, trying to tackle complex problems using an integration of approaches and methods. One important contribution to this field comes from physics through studies that attempt to identify and quantify the molecular interactions between small molecules (drugs) and biological targets (receptors), such as the forces that govern the interactions, the thermodynamics of the drug–receptor interactions, and so on. In this context, the interfaces of physics, medicinal chemistry, and drug design are of vital importance for the development of drugs that not only have the right chemistry but also the right intermolecular properties to interact at the macromolecular level, providing useful information about the principles and molecular mechanisms underlying the therapeutic action of drugs. This article highlights some of the most important connections between physics and medicinal chemistry in the design of new drugs.
    Brazilian Journal of Physics 08/2013; 43(4). DOI:10.1007/s13538-013-0149-7 · 0.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mycobacterium tuberculosis InhA (MtInhA) is an attractive enzyme to drug discovery efforts due to its validation as an effective biological target for tuberculosis therapy. In this work, two different virtual-ligand-screening approaches were applied in order to identify new InhA inhibitors' candidates from a library of ligands selected from the ZINC database. First, a 3-D pharmacophore model was built based on 36 available MtInhA crystal structures. By combining structure-based and ligand-based information, four pharmacophoric points were designed to select molecules able to satisfy the binding features of MtInhA substrate-binding cavity. The second approach consisted in using four well established docking programs, with different search algorithms, to compare the binding mode and score of the selected molecules from the aforementioned library. After detailed analyses of the results, six ligands were selected for in vitro analysis. Three of these molecules presented a satisfactory inhibitory activity with IC50 values ranging from 24 (± 2) μM to 83 (± 5) μM. The best compound presented an uncompetitive inhibition mode to NADH and 2-trans-dodecenoyl-CoA substrates, with Ki values of 24 (± 3) μM and 20 (± 2) μM, respectively. These molecules were not yet described as antituberculars or as InhA inhibitors, making its novelty interesting to start efforts on ligand optimization in order to identify new effective drugs against Tuberculosis having InhA as a target. More studies are underway to dissect the discovered uncompetitive inhibitor interactions with MtInhA.
    Journal of Chemical Information and Modeling 07/2013; 53(9). DOI:10.1021/ci400202t · 3.74 Impact Factor

Publication Stats

2k Citations
286.55 Total Impact Points


  • 2003-2014
    • University of São Paulo
      • Institute of Physics São Carlos (IFSC)
      San Paulo, São Paulo, Brazil
  • 2010
    • Universidade do Vale do Itajaí (Univali)
      • Center of Health Sciences
      Itajahy, Santa Catarina, Brazil
  • 2009
    • Universidade Federal de Santa Maria
      Santa Maria da Boca do Monte, Rio Grande do Sul, Brazil
  • 2007
    • Universidade Federal da Bahia
      • Faculdade de Farmácia
      Salvador, Estado da Bahia, Brazil
  • 1999-2006
    • University of Michigan
      • College of Pharmacy
      Ann Arbor, Michigan, United States
  • 1998-2002
    • Federal University of Santa Catarina
      • Departamento de Química
      Nossa Senhora do Destêrro, Santa Catarina, Brazil